Correlation Between Ascendis Pharma and RNI Negcios

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ascendis Pharma and RNI Negcios at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ascendis Pharma and RNI Negcios into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ascendis Pharma AS and RNI Negcios Imobilirios, you can compare the effects of market volatilities on Ascendis Pharma and RNI Negcios and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ascendis Pharma with a short position of RNI Negcios. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ascendis Pharma and RNI Negcios.

Diversification Opportunities for Ascendis Pharma and RNI Negcios

AscendisRNIDiversified AwayAscendisRNIDiversified Away100%
-0.37
  Correlation Coefficient

Very good diversification

The 3 months correlation between Ascendis and RNI is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Ascendis Pharma AS and RNI Negcios Imobilirios in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on RNI Negcios Imobilirios and Ascendis Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ascendis Pharma AS are associated (or correlated) with RNI Negcios. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of RNI Negcios Imobilirios has no effect on the direction of Ascendis Pharma i.e., Ascendis Pharma and RNI Negcios go up and down completely randomly.

Pair Corralation between Ascendis Pharma and RNI Negcios

Assuming the 90 days trading horizon Ascendis Pharma AS is expected to generate 0.7 times more return on investment than RNI Negcios. However, Ascendis Pharma AS is 1.42 times less risky than RNI Negcios. It trades about 0.01 of its potential returns per unit of risk. RNI Negcios Imobilirios is currently generating about -0.18 per unit of risk. If you would invest  5,335  in Ascendis Pharma AS on September 18, 2024 and sell it today you would earn a total of  0.00  from holding Ascendis Pharma AS or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy98.41%
ValuesDaily Returns

Ascendis Pharma AS  vs.  RNI Negcios Imobilirios

 Performance 
JavaScript chart by amCharts 3.21.15OctNovDec -20-1001020
JavaScript chart by amCharts 3.21.15A1SN34 RDNI3
       Timeline  
Ascendis Pharma AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ascendis Pharma AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Ascendis Pharma is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.
JavaScript chart by amCharts 3.21.15OctNovDecNovDec49505152535455
RNI Negcios Imobilirios 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days RNI Negcios Imobilirios has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
JavaScript chart by amCharts 3.21.15OctNovDecNovDec2.42.62.833.2

Ascendis Pharma and RNI Negcios Volatility Contrast

   Predicted Return Density   
JavaScript chart by amCharts 3.21.15-9.7-7.27-4.83-2.40.02.555.137.7210.31 0.020.040.060.08
JavaScript chart by amCharts 3.21.15A1SN34 RDNI3
       Returns  

Pair Trading with Ascendis Pharma and RNI Negcios

The main advantage of trading using opposite Ascendis Pharma and RNI Negcios positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ascendis Pharma position performs unexpectedly, RNI Negcios can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in RNI Negcios will offset losses from the drop in RNI Negcios' long position.
The idea behind Ascendis Pharma AS and RNI Negcios Imobilirios pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Complementary Tools

Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Global Correlations
Find global opportunities by holding instruments from different markets
Bonds Directory
Find actively traded corporate debentures issued by US companies